Genetic and epigenetic alterations at secondary resistance after continued decitabine-based treatment of acute myeloid leukemia in the randomized phase II DECIDER trial
在随机 II 期 DECIDER 试验中,持续接受地西他滨治疗的急性髓系白血病患者出现继发性耐药后,遗传和表观遗传改变的情况
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-025-02780-7
Hund, Inga; Hess, Maria Elena; Andrieux, Geoffroy; Stomper, Julia; Greve, Gabriele; Niemöller, Christoph; Ma, Tobias; Uhl, David; Grishina, Olga; Thol, Felicitas; Heuser, Michael; Bug, Gesine; Crysandt, Martina; Neubauer, Andreas; Duyster, Justus; Döhner, Hartmut; Boerries, Melanie; Lübbert, Michael; Becker, Heiko